{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:39:48Z","timestamp":1772815188530,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["psy-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.psychres.2014.07.013","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T07:15:30Z","timestamp":1406099730000},"page":"76-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Asymmetric dimethylarginine (ADMA) and treatment response relationship in male patients with first-episode schizophrenia: A controlled study"],"prefix":"10.1016","volume":"220","author":[{"given":"Serkan","family":"Zincir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selma Bozkurt","family":"Zincir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Doruk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cemil","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Ak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beyaz\u0131t","family":"Garip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cihad","family":"Y\u00fckselir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00fclent","family":"Karaahmeto\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2014.07.013_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000418013","article-title":"Methods for assessing positive and negative symptoms","volume":"24","author":"Andreasen","year":"1990","journal-title":"Modern Problems of Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2014.07.013_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5455\/bcp.20111212083708","article-title":"Nitric oxide and asymmetrical dimethylarginine levels in acute mania","volume":"22","author":"Aykut","year":"2012","journal-title":"Bulletin of Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.psychres.2014.07.013_bib3","first-page":"159","article-title":"Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy","volume":"58","author":"Beltowski","year":"2006","journal-title":"Pharmacological Reports"},{"issue":"7","key":"10.1016\/j.psychres.2014.07.013_bib4","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0735-1097(00)01013-5","article-title":"An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes","volume":"36","author":"Boger","year":"2000","journal-title":"Journal of the American College of Cardiology"},{"issue":"2\u20133","key":"10.1016\/j.psychres.2014.07.013_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.psychres.2011.06.003","article-title":"Plasma asymmetric dimethylarginine (ADMA) concentrations in patients with first and multiple episode schizophrenia","volume":"190","author":"Celik","year":"2011","journal-title":"Psychiatry Research"},{"issue":"2","key":"10.1016\/j.psychres.2014.07.013_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0378-4347(96)00531-2","article-title":"Determination of N(G),N(G)-dimethylarginine in human plasma by high-performance liquid chromatography","volume":"692","author":"Chen","year":"1997","journal-title":"Journal of chromatography B: Biomedical Sciences and Applications"},{"issue":"2","key":"10.1016\/j.psychres.2014.07.013_bib100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/bbrc.1995.1980","article-title":"Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain","volume":"212","author":"Das","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.1016\/j.psychres.2014.07.013_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3940(96)12972-4","article-title":"Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production","volume":"215","author":"Das","year":"1996","journal-title":"Neuroscience Letters"},{"issue":"2","key":"10.1016\/j.psychres.2014.07.013_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000026478","article-title":"Nitric oxide, free radicals and polyamines may have a role in the membrane pathology of schizophrenia","volume":"37","author":"Das","year":"1998","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.psychres.2014.07.013_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5505\/tjb.2012.76486","article-title":"Asimetrik dimetilarginin metabolizmas\u0131 ve klinik \u00f6nemi","volume":"37","author":"Erbil","year":"2012","journal-title":"Turkish Journal of Biochemistry"},{"key":"10.1016\/j.psychres.2014.07.013_bib10","first-page":"16","article-title":"Negatif semptomlar\u0131 de\u011ferlendirme \u00f6l\u00e7e\u011finin g\u00fcvenilirli\u011fi ve ge\u00e7erlili\u011fi","volume":"4","author":"Erkoc","year":"1991","journal-title":"D\u00fc\u015f\u00fcnen Adam"},{"key":"10.1016\/j.psychres.2014.07.013_bib11","first-page":"20","article-title":"Pozitif semptomlar\u0131 de\u011ferlendirme \u00f6l\u00e7e\u011finin g\u00fcvenilirli\u011fi ve ge\u00e7erlili\u011fi","volume":"4","author":"Erkoc","year":"1991","journal-title":"D\u00fc\u015f\u00fcnen Adam"},{"key":"10.1016\/j.psychres.2014.07.013_bib12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1192\/bjp.142.3.288","article-title":"Low CSF concentrations of cyclic GMP in schizophrenia","volume":"142","author":"Gattaz","year":"1983","journal-title":"The British Journal of Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2014.07.013_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1365-2362.2003.01184.x","article-title":"Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease","volume":"33","author":"Jonasson","year":"2003","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.psychres.2014.07.013_bib14","unstructured":"Lukoff, D., Nuechhtriein, K.H., Vertuna, J., 1993. Brief Psychiatric Rating Scale (BPRS) Version 3.0, Expended Version. UCLA Deoartment of Psychiatry and Biobehaviriol Sciences, West Los Angeles Medical Center, Los Angeles."},{"issue":"2\u20133","key":"10.1016\/j.psychres.2014.07.013_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0920-9964(03)00070-7","article-title":"Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study","volume":"68","author":"Ramirez","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.07.013_bib16","first-page":"586","article-title":"Asymmetric dimethylarginine\u2014comparison of HPLC and ELISA methods","volume":"850","author":"Siroka","year":"2007","journal-title":"Journal of Chromatography"},{"issue":"7","key":"10.1016\/j.psychres.2014.07.013_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.seizure.2011.04.001","article-title":"MTHFR, MTR, and MTHFD1 gene polymorphisms compared to homocysteine and asymmetric dimethylarginine concentrations and their metabolites in epileptic patients treated with antiepileptic drugs","volume":"20","author":"Sniezawska","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.psychres.2014.07.013_bib18","series-title":"Institutional differences, and case typicality as related to diagnosis system severity, prognosis and treatment","author":"Soykan","year":"1989"},{"issue":"2","key":"10.1016\/j.psychres.2014.07.013_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s002130100860","article-title":"Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients","volume":"158","author":"Srivastava","year":"2001","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.psychres.2014.07.013_bib20","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.287.11.1420","article-title":"Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor","volume":"287","author":"Stuhlinger","year":"2002","journal-title":"The Journal of the American Medical Association"},{"issue":"4","key":"10.1016\/j.psychres.2014.07.013_bib21","first-page":"288","article-title":"Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia","volume":"28","author":"Suzuki","year":"2003","journal-title":"Journal of Psychiatry and Neuroscience"},{"issue":"8793","key":"10.1016\/j.psychres.2014.07.013_bib22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.psychres.2014.07.013_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/00365510310002040","article-title":"Asymmetric dimethylarginine and total homocysteine in plasma after oral methionine loading","volume":"63","author":"Wanby","year":"2003","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178114005885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178114005885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T03:09:41Z","timestamp":1565665781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178114005885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0165178114005885"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2014.07.013","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymmetric dimethylarginine (ADMA) and treatment response relationship in male patients with first-episode schizophrenia: A controlled study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2014.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}